| Literature DB >> 34221863 |
Yang Yu1,2, Changliang Yao1, De-An Guo1,2.
Abstract
Traditional Chinese medicine (TCM) has been an indispensable source of drugs for curing various human diseases. However, the inherent chemical diversity and complexity of TCM restricted the safety and efficacy of its usage. Over the past few decades, the combination of liquid chromatography with mass spectrometry has contributed greatly to the TCM qualitative analysis. And novel approaches have been continuously introduced to improve the analytical performance, including both the data acquisition methods to generate a large and informative dataset, and the data post-processing tools to extract the structure-related MS information. Furthermore, the fast-developing computer techniques and big data analytics have markedly enriched the data processing tools, bringing benefits of high efficiency and accuracy. To provide an up-to-date review of the latest techniques on the TCM qualitative analysis, multiple data-independent acquisition methods and data-dependent acquisition methods (precursor ion list, dynamic exclusion, mass tag, precursor ion scan, neutral loss scan, and multiple reaction monitoring) and post-processing techniques (mass defect filtering, diagnostic ion filtering, neutral loss filtering, mass spectral trees similarity filter, molecular networking, statistical analysis, database matching, etc.) were summarized and categorized. Applications of each technique and integrated analytical strategies were highlighted, discussion and future perspectives were proposed as well.Entities:
Keywords: BS, background subtraction; CCS, collision cross section; CE, collision energy; CID, collision-induced dissociation; DDA, data-dependent acquisition; DE, dynamic exclusion; DIA, data-independent acquisition; DIF, diagnostic ion filtering; DM, database matching; Data acquisition; Data post-processing; EL, exclusion list; EMS, enhanced mass spectrum; EPI, enhanced product ion; FS, full scan; HCD, high-energy C-trap dissociation; IDA, information dependent acquisition; IM, ion mobility; IPF, isotope pattern filtering; ISCID, in-source collision-induced dissociation; LC, liquid chromatography; LTQ-Orbitrap, linear ion-trap/orbitrap; Liquid chromatography−mass spectrometry; MDF, mass defect filtering; MIM, multiple ion monitoring; MN, molecular networking; MRM, multiple reaction monitoring; MS, mass spectrometry; MTSF, mass spectral trees similarity filter; NL, neutral loss; NLF, neutral loss filtering; NLS, neutral loss scan; NRF, nitrogen rule filtering; PCA, principal component analysis; PIL, precursor ion list; PIS, precursor ion scan; PLS-DA, partial least square-discriminant analysis; Q-TRAP, hybrid triple quadrupole-linear ion trap; QSRR, quantitative structure retention relationship; QqQ, triple quadrupole; Qualitative analysis; RT, retention time; SA, statistical analysis; TCM, traditional Chinese medicine; Traditional Chinese medicine; UHPLC, ultra-high performance liquid chromatography; cMRM, conventional multiple reaction monitoring; sMRM, scheduled multiple reaction monitoring
Year: 2021 PMID: 34221863 PMCID: PMC8245813 DOI: 10.1016/j.apsb.2021.02.017
Source DB: PubMed Journal: Acta Pharm Sin B ISSN: 2211-3835 Impact factor: 11.413
Figure 1Data acquisition and data post-processing techniques of LC−MS in TCM qualitative analysis. PIL, precursor ion list; DE, dynamic exclusion; PIS, precursor ion scan; NLS, neutral loss scan; MRM, multiple reaction monitoring; MDF, mass defect filtering; BS, background subtraction; IPF, isotope pattern filtering; DIF, diagnostic ion filtering; NLF, neutral loss filtering; MTSF, mass spectral trees similarity filter, MN: molecular networking; SA, statistical analysis; DM, database matching.
Applications of LC−MS in TCM qualitative analysis.
| TCM sample | Mass analyzer | Data acquisition technique | Data post-processing technique | Characterization result | Ref. |
|---|---|---|---|---|---|
| Q-TOF | MSAll; SWATH | DIF | 89 triterpene saponins, along with 14 sapogenins, including 33 potentially new compounds and the first report of malonyl-saponin in genus | ||
| Q-TOF | IMS-MSE | DM; NLF | 121 lanostane-type triterpene acids, including three new compounds | ||
| Yi-Xin-Shu capsule | Q-TOF | PIL-MS/MS | DIF | 276 compounds, including 50 lignans, 30 tanshinones, 4 lactones, 18 flavones, 14 phenolicacids, 1 triterpenoid acid, 3 ophiopogonins, 7 astragalus saponins, and 149 ginsenosides | |
| Erzhi pill | Q-Orbitrap | Full MS/PIL/dd-MS2; “If idle-pick others” (IIPO); DE | MDF; NLF; DIF | 146 components, including 25 triterpenes, 31 flavonoids, 46 iridoids, 16 phenylethanols, 3 coumarins, 12 phenols, and 13 others | |
| LTQ-Orbitrap | PIL-DE-CID/MS2-HCD/MS3 | BS; MDF; DM | 158 potentially new alkaloids, including 10 unknown but predicted and 108 unexpected ones | ||
| Three different parts (the root, stem leaf, and flower bud) of | Q-Orbitrap | Full MS/PIL/IIPO/dd-MS2; DE | MDF | 347 saponins (147 from root, 173 from stem leaf, and 195 from flower bud), and 157 thereof not ever-isolated from the | |
| LTQ-Orbitrap | PIL; DE | NLF | 66 compounds, including 43 malonates of isoflavone glycoside | ||
| LTQ-Orbitrap | ISCID-FS; PIL-HCD-MS/MS; DE | NLF | 101 malonyl-ginsenosides, including 69 from | ||
| LTQ-Orbitrap | HCD-MS2; PIL-CID-MS4; FS-MS | MN; DM | 106 triterpene saponins including 49 potentially new ones | ||
| Q-Orbitrap | full MS/PIL/dd-MS2; IIPO; DE | Retention behavior; Reference compounds comparison; Elemental composition analysis; Fragmentation pathways interpretation; DM | 13 primary metabolites (1 nucleoside, 2 sugars, 5 organic alkali/acids, and 5 amino acids) and 135 secondary metabolites (97 quinochalcone | ||
| Ligustri Lucidi Fructus | Q-Orbitrap | Full MS/PIL/dd-MS2; IIPO; DE; Polarity switching | Reference compounds comparison; Elemental composition analysis; Fragmentation pathways analysis; DM | 158 components, including 137 in the negative mode and 21 in the positive mode | |
| LTQ-Orbitrap | FS-PIL-DE | DIF | 135 polymethoxylated flavonoids, including 81 polymethoxyflavones, 54 polymethoxyflavanones or polymethoxychalcones | ||
| LTQ-Orbitrap | PIL-MS | Predicted compounds filtering; Total ion chromatogram filtering; Fragment ion search | 190 polymeric phenolic acids, including 18 first detected ones | ||
| Lonicerae Japonicae Flos | Q-Obitrap | EL-dd-MS2 | DM; MN | A total of 537 compounds, including a large number of potential novel structures | |
| LTQ-Orbitrap | FS-DE-MS1; HCD-MS2 (−); CID-MS2 (−); CID-MS3 (−); Product ion-MS4 (−); CID-MS2 (+); NL-MS3 (+) | – | 78 dicarboxylic acid conjugated bufotoxins, including 68 new compounds, 25 types of substructure formulas and seven dicarboxylic acid side chains | ||
| Roots, leaves, and flower buds of | LTQ-Orbitrap | ISCID-FS-MS1; Mass tag/CID-MS2; NLS/HCD-MS3; DE | – | 178 malonylginsenosides | |
| LTQ-Orbitrap | ISCID-FS-MS1; Mass tag/CID-MS2; Product ion scan/CID-MS3; DE | NLF | 216 carboxyl-free ginsenosides | ||
| Processed | QTOF; QqQ | PIS | – | 24 benzoyl-containing alkaloids | |
| Q-TRAP | PIS | – | 10 caffeoylquinic acid derivatives | ||
| QqQ; QTOF | PIS; Product ion scan | – | 74 oplopane- and bisabolene- sesquiterpenoids, and isolation of 11 compounds | ||
| QqQ; QTOF | NLS; PIS | – | 50 triterpene saponins | ||
| QqQ | PIS; FS; Product ion scan | DIF; NLF | 110 polyoxypregnane and its glycosides | ||
| QqQ | Two-step PIS | – | 17 flavonoids, including 9 newly identified ones | ||
| Danhong injection | QTRAP | EMS-IDA-EPI; PIS-IDA-EPI | DM | 90 compounds, including 46 salvianolic acids and related phenolic compounds | |
| QTRAP; QTOF | EMS-EPI; Stepwise MIM-EPI; PIS-EPI | NLF | 48 naphthoquinones including 24 novel ones | ||
| Radix Glehniae | QTRAP | MIM-IDA-EPI; PIS-IDA-EPI | – | 41 coumarins | |
| QTRAP | EMS-IDA-EPI; Predefined MRM-IDA-EPI; PIS-IDA-EPI; NL-IDA-EPI | DM | 513 components detected, including 379 annotated compounds | ||
| Tobacco leaves | QqQ | NLS; Product ion scan | DM | 64 glycosides, including 39 glycosides linked with monosaccharides, 18 glycosides linked with disaccharides and 7 glycosides linked with trisaccharides | |
| Astragali Radix (Huangqi) | QTRAP | MIM-EPI; PI-EPI; NL-EPI; MRM-EPI | Extracted ion chromatogram; DIF; NLF | 421 flavonoids | |
| Astragali Radix | QTRAP | NL/PIS-IDA-enhanced resolution-EPI | – | 136 triterpenoid saponins | |
| QTRAP | NLS | – | 27 sulfated flavonoids | ||
| Ion trap | FS; MS | DIF; NLF | 77 flavonoid glycosides | ||
| Alismatis Rhizoma and processed Alismatis Rhizoma | QTOF; QTRAP | FS; MS/MS; MRM | DIF; NLF | 80 triterpenes including 14 novel compounds; 7 more triterpenes compounds in the processed | |
| QTRAP | MRM-IDA-EPI | – | 27 components, including eighteen diterpenoids, six phenolic acids, and three flavonoids | ||
| Turmeric | TripleTOF; QTRAP | CID-MS/MS; MRM-EPI | BS; DIF; Ring double bond equivalents calculation | 96 curcuminoids | |
| Ginseng, American ginseng, and processed products | QTRAP | Step-wise MRM-IDA-EPI; sMRM | PCA | 221 ginsenosides, including 185 annotated ones | |
| Shenfu injection | QTRAP | Predefined MRM-IDA-EPI; Step-wise MIM-IDA-EPI | DM | 157 detected hydrophilic compounds, and 154 of which were identified as amino acids, nucleosides, organic acid, carbohydrates, etc.; 40 primary hydrophilic and hydrophobic ingredients including 11 amino acids, 9 nucleosides, 9 aconite alkaloids, and 11 ginsenosides | |
| LTQ-Orbitrap | FS-MS1; CID-MS2; CID-MS3; DE-HCD-MS/MS | DIF; Ring double bond equivalent; Characteristic UV absorption; Diagnostic product ions analysis | 163 quinochalcone | ||
| LTQ-Orbitrap | CID-MS1-MS2-MS3; DE-HCD-MS1-MS2 | DIF; NLF; DM | 107 flavonoids, including 80 newly reported flavonoid | ||
| Q-TOF; IT-TOF | FS; MS1-MS2-MS3 | MDF | More than 50 ophiopogonins and 27 ophiopogonones | ||
| Yin Chen Si Ni Tang | Q-TOF | MSE | MDF | 62 | |
| LTQ-Orbitrap | DE-CID-MS4 | MDF; NLF; DIF; DM | 92 alkaloids (60 free alkaloids and 32 alkaloid | ||
| Processed Semen Strychni | IT-TOF | FS; MS2 and MS3 | MDF; DIF | 24 dihydroindole-type alkaloids, including 4 that were previously not described | |
| LTQ-Orbitrap | MS and MS/MS | MDF; DIF | 81 polymethoxylated flavonoids, including 50 polymethoxyflavones and 31 polymethoxyflavanones or polymethoxychalcones | ||
| Folium Artemisiae Argyi | Q-Orbitrap | FS; MS/MS | NRF; MDF; NLF; DIF | 16 methoxylated flavonoids and 55 chlorogenic acids analogues | |
| Q-TOF | MS; Auto MS/MS; targeted MS/MS | MDF; Characteristic isotopic distribution | 234 ginsenosides including 67 potential new ones | ||
| Five botanical origins of Uncariae Ramulus Cum Unicis | LTQ-Orbitrap | DE-step-wise PIL-CID/MS2-HCD/MS3 | Elemental composition analysis; NLF; DIF; DM | 1227 indole alkaloids | |
| Er-xian decoction | LTQ FT | FS; DE-CID-MS2; CID-MS3 | MTSF; Discriminant analysis; BS | 553 potential compounds and 66 candidates | |
| Arnebiae Radix | Q-Orbitrap | Full MS; MS/MS | BS; DM; MDF | 96 compounds, 13 of which were confirmed by the reference standards, 30 with a low abundance, and 9 unknowns | |
| LTQ-Orbitrap | FS; DDA | IPF | 12 | ||
| Q-TOF | MSE; CID-MS/MS | DIF | 8 potentially new C6–C2 glucoside conjugates | ||
| Zicao | Q-TOF | MS; MS/MS | BS; DIF; Characteristic product ion filtering | 58 compounds including 32 novel ones | |
| Akebiae Fructus | Q-TOF | MSE | Adduct ion filtering; DIF; Characteristic ion filtering; NLF | 94 compounds (85 triterpenoid saponins and 9 chlorogenic acids), including 9 types of triterpenoid saponins and 2 types of chlorogenic acid; 50 newly discovered constituents | |
| Q-TOF | FS in both positive and negative modes; (−)-MS/MS | DM; DIF | 38 compounds, including 36 flavonoids and 2 non-flavonoid compounds | ||
| Q-Orbitrap | FS; MS/MS | DIF | 132 compounds, 59 of which were reported for the first time | ||
| LTQ-Orbitrap | FS; MS/MS | DIF | 21 molecules, 17 of which were found to belong to the targeted chemical groups, including 8 isoflavones, 7 dihydroisoflavones and 2 isoflavone glycosides | ||
| Roots and berries of raw and steamed American ginseng ( | TOF; Q-TOF | FS; CID-MS/MS | DIF | 70 saponins | |
| Fresh and processed ginseng | Q-TOF | FS; CID-MS/MS | DIF; NLF | 12 malonyl ginsenosides | |
| Q-TOF | MS; MS/MS | DIF | A total of 29 compounds, comprising 18 alkaloids, 6 flavonoids, and 5 quinic acids; 4 novel tetracyclic monoterpenoid oxindole alkaloids (TMOAs) | ||
| Q-TOF | MS; MS/MS | DIF | 37 lycorine-type alkaloids, including 16 previously undescribed compounds | ||
| Calyx of | Q-TOF | MS; MS/MS | DIF; NLF | 46 physalins, including 20 novel ones | |
| Glechomae Herba | Q-TOF | MS; MS/MS | DIF; NLF | 120 compounds, including 10 chlorogenic acids, 10 gallic acids, 21 phenylpropionic acids and 77 flavonoids; 65 newly discovered constituents; 4 types of chlorogenic acids, 3 types of galloylglucoses, 3 types of phenylpropionic acid skeletons, and 5 types of flavonoid aglycone skeletons | |
| Raw and processed pieces of | Q-TOF | (−)-MS; (−)-MS/MS | DM; DIF | 73 characteristic markers | |
| QTOF | MS/MS; ISCID MS/MS; ISCID combined with TAP fragmentation; IM-MSE; IM-MS/MS | DIF | 140 potential polycyclic polyprenylated acylphloroglucinols (PPAPs), including 7 pairs coeluting isobaric PPAPs that were indistinguishable by conventional UHPLC−HRMS alone | ||
| Shengmai injection | IT-TOF | MS1, MS2, MS3 | DIF | More than 30 ginsenosides and 20 lignans | |
| Guge Fengtong tablet | Q-TOF | FS | DIF | 47 components, including 18 phenolic acids, 8 saponins, 14 gingerol-related compounds, and 7 diarylhepatonoids | |
| Yindan Xinnaotong soft capsule | Q-TOF; QqQ | FS; MRM | DM; DIF; MDF; NLF | 124 compounds, including 44 flavonoids, 31 phenolic acids, 20 tanshi-nones, 16 saponins, 6 ginkgolides, 5 sulfides, camphor and borneol | |
| Roots of | LTQ-Orbitrap | FS; CID-MS2-MS3 | NLF | 42 diester-diterpenoid alkaloids; 23 potential new compounds, including 16 short chain fatty acyls diester-diterpenoid alkaloids, 4 | |
| LTQ FT | DE-CID-MS3 | MTSF | 38 compounds, including 19 flavones, 11 phenylpropanoids and 8 sphingolipids; among them, 7 flavonoids, 8 phenylpropanoids and 8 sphingolipids were identified for the first time in | ||
| LTQ-Orbitrap | FS; CID-MS2; DE | MTSF | 47 chlorogenic acids, including 19 monoacyl-quinic acids, 22 diacyl-quinic acids, and six triacyl-quinic acids | ||
| Flos Lonicerae Japonicae | LTQ-Orbitrap | FS; FS-PIL; MIM | DM; MTSF; DIF | 115 chlorogenic acids attributed to 18 categories, most of which were newly reported | |
| Xiao-Xu-Ming decoction | LTQ FT | FS; DE-CID-MS2; CID-MS3 | MTSF | 68 compounds among 3362 detected compounds, including 14 templated compounds (reference compounds), 50 related compounds fished by MTSF technique, and 4 unrelated compounds identified by manual method | |
| Venenum Bufonis | Q-TOF | Fast DDA | MN | 229 bufadienolides, including two subclasses of compounds (bufogeninsconjugated with carboxylic acid and | |
| Aconiti Lateralis Radix Praeparata and its processed products | Q-TOF | MSE | MN | 145 diterpenoid alkaloids, including 78 C19 (19 diester-diterpenoid alkaloids, 20 monoester-diterpenoid alkaloids, 7 lipo-diterpenoid alkaloids, 32 amine-diterpenoid alkaloids), 13 C20, and 54 other diterpenoid alkaloids | |
| Danhong injection | Q-Orbitrap | FS | SA | 117 compounds, including 76 phenolic acids, 20 flavonoids, and 21 other compounds | |
| QqQ | NL/PIS | SA | 846 terpecurcumins (terpene-conjugated curcuminoids), including a number of potentially novel compounds | ||
| Q-TOF | MS; MS/MS | DIF; NLF; SA | 87 phenylethanoid glycosides, including 14 isomers | ||
| Ziziphi Spinosae Semen and Ziziphi Mauritianae Semen | Q-TOF | MSE | DM; DIF; NLF | 60 target components in Ziziphi Spinosae Semen, including 27 flavonoids, 16 saponins, 10 alkaloids, 6 terpenes, and 1 other, and 53 nontarget components with 40 new deduced components; 132 chemical components in Ziziphi Mauritianae Semen, including 7 additional nontarget new components | |
| Peanut stems and leaves | Q-TOF | MSE | DM | 283 chemical compounds, including 207 new compounds | |
| White and red ginsengs | Q-TOF | IM-MSE; IM-MS/MS | DM | 201 ginsenosides, including 10 pairs of co-eluting isobaric ginseng saponins | |
| Stems and leaves of | LTQ-Orbitrap | DE-CID-MS3; DE-HCD-MS2 | NLF; DIF; DM | 646 ginsenosides, including 427 which have not been isolated from the genus of | |
| Five different parts (root, leaf, flower bud, berry, and seed) of | Q-TOF | MSE | DM | 164 compounds | |
| Q-TOF | Fast DDA | DM; DIF; NLF | 945 ginsenosides, including 662 potentially novel ginsenosides | ||
| Baoyuan decoction | Q-TOF; QTRAP | FS-MS1; MSE; Predefined MRM-EPI, MIM-EPI, and PIS-EPI | DM; DIF | 236 compounds, including 139 saponins, 83 flavonoids, 6 procyanidins, 4 lignans, and 4 diterpenes | |
| Q-TOF | MSE | DM | 146 metabolites, including 42 potential new compounds | ||
| Q-TOF | MSE; HDMSE | DM | 24 potential lipid markers enabling the simultaneous differentiation of three | ||
| LTQ-Orbitrap | FS-HRMS; MS/MS; DE | DM; Parent mass modification search; DIF; MTSF | 69 phenylethanoid glycosides, including 17 new ones | ||
| Q-TOF | MS; MS/MS | DM | 148 lipo-alkaloids, including 93 potential new compounds and 38 compounds with oxygenated fatty acid moieties | ||
| Q-TOF | MS/MS | DM | 57 components, including 43 alkaloids, 9 iridoids, 2 steroids, 2 phenolic acids and 1 coumarin |
Selection criteria of data acquisition and post-processing techniques in TCM qualitative analysis.
| Technique | Advantage | Limitation | Scope of application | |
|---|---|---|---|---|
| DIA | DIA | Full coverage of MS1 and MS2 information | Loss link between precursor and product ions | Acquisition of MS/MS information of minor or trace compounds |
| DDA | PIL | Screening of only (or preferred) target ions in the list | Miss of novel compounds with new sub-structures or substituted groups | Target compounds with predictable molecular weights and/or |
| DE | Detection of less abundant co-eluting ions | Quality loss of MS2 information of abundant ions | MS/MS information of both abundant and less abundant compounds in complex samples | |
| Mass tag | Selective screening of compounds that undergo in-source fragmentations | Not applicable to relatively stable compounds that cannot generate certain in-source fragmentation patterns | Compounds that can undergo certain in-source fragmentations with ISCID energy | |
| PIS | Requirements of little prior-knowledge about the exact structure of target compounds | Miss of compounds without selected product ions | Compounds with known specific product ions | |
| NLS | Targeted screening of modified or conjugated compounds that undergo neutral eliminations | Only compounds with certain neutral eliminations | Compounds with certain neutral eliminations | |
| MRM | High selectivity and sensitivity in screening target compounds | Low resolution and unable to screen unknown compounds without information of parent and product ions | Target compounds with known parent and product ions | |
| Data post-processing | MDF | Selective screening of certain compounds or compound classes and remove of interferences | Requirements of a carefully-designed appropriate MDF region | Compounds with predictable mass range and mass defect range |
| BS | Elimination of background signals, and exposure of target compounds | Poor selectivity of target compounds | Severe background interferences | |
| IPF | Specific screening of compounds with certain elements | Relatively narrow application scope | Compounds with distinct isotope pattern | |
| DIF | Rapid screening of target compounds that produce identical product ions | Miss of compounds without selected product ions | Compounds with known product ion | |
| NLF | Compounds that undergo neutral eliminations | Only compounds with certain neutral eliminations | Compounds with specific neutral loss | |
| MTSF | Rapid classification and characterization of unknown compounds | Need of MS | Target compounds sharing the same sub-structures and similar MS | |
| MN | Rapid classification and characterization of compounds without prior knowledge of the chemical structures | Manual interpretation of detailed structure information of unknown compounds based on the related known compounds | Compounds with MS/MS spectra | |
| SA | Rapid exploration of intrinsic relationships between compound structures and MS data | Further characterization and identification of compounds | Recognition of potential characteristic ions, discrimination of different structures and isomers | |
| DM | Alleviation of labor for mining structural information from large-scale datasets | Limited records in databases and requirements of further manual confirmation | Automatic search and annotation of compounds through on-line or in-house databases | |
Figure 2A decision tree that represents a possible way to select an LC–MS based data acquisition/post-processing strategy.